治疗用药豁免。

Medicine and sport science Pub Date : 2017-01-01 Epub Date: 2017-06-01 DOI:10.1159/000460700
David Gerrard, Andrew Pipe
{"title":"治疗用药豁免。","authors":"David Gerrard,&nbsp;Andrew Pipe","doi":"10.1159/000460700","DOIUrl":null,"url":null,"abstract":"<p><p>The introduction, in 2004, of the World Anti-Doping Code and a standardized \"prohibited list\" of substances and methods proscribed in sport represented a consistent, international response to the escalating challenge of drug misuse in contemporary sport. Simultaneously, it was recognized that athletes experiencing illness or injury might legitimately require the use of \"prohibited\" medications or procedures, and the concept of the \"therapeutic use exemption\" (TUE) was introduced. The mechanisms of the TUE process are carefully defined and described in a specific WADA \"international standard\" (IS). As a consequence, anti-doping organizations (ADOs) were empowered to establish \"Therapeutic Use Exemption Committees\" (TUECs) whose membership and responsibilities were clearly delineated in the IS, and to whom an athlete and treating physician(s) could make appropriate application for a TUE. A careful review of such an application by a TUEC panel of physicians might allow permission for an otherwise prohibited course of treatment, provided that appropriate criteria had been met. Sport physicians have a clear responsibility to ensure accurate and complete documentation of the clinical circumstances requiring a TUE when completing such applications. Typically, applications for consideration by TUECs are forwarded to a national ADO, but depending on an applicant's level of competition, it may become necessary to involve an international federation or major event organization (e.g., International Olympic Committee, or Commonwealth Games Federation). Such organizations may receive, review, and grant TUEs specific to the competitions over which they preside. Increasingly, there is recognition of TUEs granted by other ADOs. However, this is not always the case; in certain circumstances, the decisions of other TUECs to grant or deny an application may be appealed. The advent of the TUE process ensures that an athlete with a genuine medical condition that necessitates the use of a prohibited substance or procedure can apply for permission to use such treatments and is not denied access to competition or training.</p>","PeriodicalId":18475,"journal":{"name":"Medicine and sport science","volume":"62 ","pages":"55-67"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000460700","citationCount":"20","resultStr":"{\"title\":\"Therapeutic Use Exemptions.\",\"authors\":\"David Gerrard,&nbsp;Andrew Pipe\",\"doi\":\"10.1159/000460700\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The introduction, in 2004, of the World Anti-Doping Code and a standardized \\\"prohibited list\\\" of substances and methods proscribed in sport represented a consistent, international response to the escalating challenge of drug misuse in contemporary sport. Simultaneously, it was recognized that athletes experiencing illness or injury might legitimately require the use of \\\"prohibited\\\" medications or procedures, and the concept of the \\\"therapeutic use exemption\\\" (TUE) was introduced. The mechanisms of the TUE process are carefully defined and described in a specific WADA \\\"international standard\\\" (IS). As a consequence, anti-doping organizations (ADOs) were empowered to establish \\\"Therapeutic Use Exemption Committees\\\" (TUECs) whose membership and responsibilities were clearly delineated in the IS, and to whom an athlete and treating physician(s) could make appropriate application for a TUE. A careful review of such an application by a TUEC panel of physicians might allow permission for an otherwise prohibited course of treatment, provided that appropriate criteria had been met. Sport physicians have a clear responsibility to ensure accurate and complete documentation of the clinical circumstances requiring a TUE when completing such applications. Typically, applications for consideration by TUECs are forwarded to a national ADO, but depending on an applicant's level of competition, it may become necessary to involve an international federation or major event organization (e.g., International Olympic Committee, or Commonwealth Games Federation). Such organizations may receive, review, and grant TUEs specific to the competitions over which they preside. Increasingly, there is recognition of TUEs granted by other ADOs. However, this is not always the case; in certain circumstances, the decisions of other TUECs to grant or deny an application may be appealed. The advent of the TUE process ensures that an athlete with a genuine medical condition that necessitates the use of a prohibited substance or procedure can apply for permission to use such treatments and is not denied access to competition or training.</p>\",\"PeriodicalId\":18475,\"journal\":{\"name\":\"Medicine and sport science\",\"volume\":\"62 \",\"pages\":\"55-67\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1159/000460700\",\"citationCount\":\"20\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicine and sport science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1159/000460700\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2017/6/1 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine and sport science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000460700","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/6/1 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 20

摘要

2004年,《世界反兴奋剂条例》(World Anti-Doping Code)和一份体育运动中禁用物质和方法的标准化“禁用清单”的出台,代表了国际社会对当代体育运动中不断升级的药物滥用挑战的一致回应。同时,人们认识到,患病或受伤的运动员可能会合法地要求使用“禁止的”药物或程序,并引入了“治疗性使用豁免”(TUE)的概念。在WADA特定的“国际标准”(IS)中,仔细定义和描述了TUE过程的机制。因此,反兴奋剂组织(ADOs)被授权建立“治疗用药豁免委员会”(TUEC),其成员和职责在IS中有明确规定,运动员和治疗医生可以向其提出适当的TUE申请。如果符合适当的标准,由TUEC医生小组对此类申请进行仔细审查,可能会允许使用其他禁止的治疗过程。在完成此类申请时,运动医生有明确的责任确保准确和完整地记录需要进行TUE的临床情况。通常情况下,由tuec考虑的申请被转发给国家ADO,但根据申请人的竞争水平,可能需要涉及国际联合会或主要活动组织(例如,国际奥委会或英联邦运动会联合会)。这些组织可以接收、审查和授予针对其主持的竞赛的技术指导费。越来越多的地方认可了其他的技术转让单位。然而,情况并非总是如此;在某些情况下,可就其他东华理工大学批准或拒绝申请的决定提出上诉。医用药物和药物治疗程序的出现确保了有真正的健康状况需要使用禁用物质或程序的运动员可以申请使用此类治疗的许可,并且不会被拒绝参加比赛或训练。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Therapeutic Use Exemptions.

The introduction, in 2004, of the World Anti-Doping Code and a standardized "prohibited list" of substances and methods proscribed in sport represented a consistent, international response to the escalating challenge of drug misuse in contemporary sport. Simultaneously, it was recognized that athletes experiencing illness or injury might legitimately require the use of "prohibited" medications or procedures, and the concept of the "therapeutic use exemption" (TUE) was introduced. The mechanisms of the TUE process are carefully defined and described in a specific WADA "international standard" (IS). As a consequence, anti-doping organizations (ADOs) were empowered to establish "Therapeutic Use Exemption Committees" (TUECs) whose membership and responsibilities were clearly delineated in the IS, and to whom an athlete and treating physician(s) could make appropriate application for a TUE. A careful review of such an application by a TUEC panel of physicians might allow permission for an otherwise prohibited course of treatment, provided that appropriate criteria had been met. Sport physicians have a clear responsibility to ensure accurate and complete documentation of the clinical circumstances requiring a TUE when completing such applications. Typically, applications for consideration by TUECs are forwarded to a national ADO, but depending on an applicant's level of competition, it may become necessary to involve an international federation or major event organization (e.g., International Olympic Committee, or Commonwealth Games Federation). Such organizations may receive, review, and grant TUEs specific to the competitions over which they preside. Increasingly, there is recognition of TUEs granted by other ADOs. However, this is not always the case; in certain circumstances, the decisions of other TUECs to grant or deny an application may be appealed. The advent of the TUE process ensures that an athlete with a genuine medical condition that necessitates the use of a prohibited substance or procedure can apply for permission to use such treatments and is not denied access to competition or training.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信